✦ LIBER ✦

Can the development of cardiac dysfunction in patients with liver cirrhosis and portal hypertension be predicted?

✍ Scribed by Manov, Emil Ivanov; Runev, Nikolay Margaritov; Donova, Temenuga Ivanova; Tchernev, Konstantin Georgiev

Book ID: 122144166
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 244 KB
Volume: 168
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2012.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac dysfunction in portal hypertensi

Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis

✍ Binay K De; Debabrata Majumdar; Debasish Das; Pranab K Biswas; Sanjay K Mandal; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

710 TIMP-1 IN PATIENTS WITH CIRRHOSIS: R

710 TIMP-1 IN PATIENTS WITH CIRRHOSIS: RELATION TO LIVER DYSFUNCTION, PORTAL HYPERTENSION, AND HAEMODYNAMIC CHANGES

✍ Busk, T.M.; Bendtsen, F.; Jensen, V.; Nielsen, H.J.; Brünner, N.; Moller, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Incidence and progression of portal hype

Incidence and progression of portal hypertensive gastropathy in patients with liver cirrhosis

✍ G. Nicolini; S. Angeloni; O. Riggio; V. Rinaidi; A.F. Attili; M. Merli 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Reduced portal flow-rate as predictive f

Reduced portal flow-rate as predictive factor of portal vein thrombosis development in patients with liver cirrhosis

✍ M.A. Zocco; M. Novi; E. Di Stasio; L. Riccardi; A. Forgione; R. De Cristofaro; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Ascorbic acid improves the intrahepatic

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

✍ Manuel Hernández-Guerra; Juan C. García-Pagán; Juan Turnes; Pablo Bellot; Ramón 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 1 views

Patients with cirrhosis show intrahepatic endothelial dysfunction, characterized by an impaired flow-dependent vasorelaxation. This alteration is responsible for the marked postprandial increase in portal pressure and is attributed to an insufficient release of nitric oxide (NO). Ascorbic acid rever

Diffusion-weighted imaging (DWI) of the

Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension

✍ Klasen, Janina; Lanzman, Rotem Shlomo; Wittsack, Hans-Jörg; Kircheis, Gerald; Sc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 614 KB